Influenza With and Without Oseltamivir Treatment and Pediatric Neuropsychiatric Events
James W. Antoon, MD, PhD, MPH, recently published an original investigation in JAMA Neurology on the use of the influenza antiviral oseltamivir associated with serious neuropsychiatric events. Dr. Antoon is an Assistant Professor of Pediatrics, Hospital Medicine at the Vanderbilt University Medical Center and Pediatric Hospitalist at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
SPR Member
Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents
“Question Is the use of the influenza antiviral oseltamivir associated with serious neuropsychiatric events?
Findings In this cohort study, the risk of serious neuropsychiatric events was lowest during periods without influenza. During influenza periods, treatment with oseltamivir was associated with a reduced risk of serious neuropsychiatric events compared with influenza periods without oseltamivir treatment.”
